Cashman Neil has filed 8 insider transactions across 1 company since August 2023.
Most recent transaction: a grant/award of 4122 shares of ProMIS Neurosciences Inc. ($PMN) on February 03, 2026.
Activity breakdown: 1 open-market purchase and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 3, 2026 | ProMIS Neurosciences Inc. | $PMN | Cashman Neil | Chief Scientific Officer | A | Common Shares | 4122 | $12.13 | 9,318.0000 | 48,833,799 | 79.33% | 0.01% |
| Feb. 3, 2026 | ProMIS Neurosciences Inc. | $PMN | Cashman Neil | Chief Scientific Officer | A | Warrants to purchase Common Shares | 4122 | $0.00 | 4,122.0000 | 48,833,799 | 9999.99% | 0.01% |
| Sept. 22, 2025 | ProMIS Neurosciences Inc. | $PMN | Cashman Neil | Chief Scientific Officer | A | Option (right to buy) | 165000 | $0.00 | 165,000.0000 | 34,851,203 | 9999.99% | 0.47% |
| Feb. 10, 2025 | ProMIS Neurosciences Inc. | $PMN | Cashman Neil | Chief Scientific Officer | P | Common Shares | 15000 | $0.97 | 129,921.0000 | 26,461,731 | 13.05% | 0.06% |
| Nov. 18, 2024 | ProMIS Neurosciences Inc. | $PMN | Cashman Neil | Chief Scientific Officer | A | Option (right to buy) | 200000 | $0.00 | 200,000.0000 | 30,067,095 | 9999.99% | 0.67% |
| Oct. 26, 2023 | ProMIS Neurosciences Inc. | $PMN | Cashman Neil | Chief Scientific Officer | A | Option (right to buy) | 12500 | $0.00 | 12,500.0000 | 12,370,830 | 9999.99% | 0.10% |
| Aug. 23, 2023 | ProMIS Neurosciences Inc. | $PMN | Cashman Neil | Chief Scientific Officer | A | Common Shares | 10643 | $0.00 | 114,921.0000 | 8,579,284 | 10.21% | 0.12% |
| Aug. 23, 2023 | ProMIS Neurosciences Inc. | $PMN | Cashman Neil | Chief Scientific Officer | A | Warrants to purchase Common Shares | 10643 | $0.00 | 10,643.0000 | 8,579,284 | 9999.99% | 0.12% |